HemaSphere
(Oct 2022)
P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
- Ioanna Xagoraris,
- Konstantina Stathopoulou,
- Stefanie Renken,
- Andreas Lundqvist,
- Francois Xavier Claret,
- Elias Drakos,
- Georgios Z. Rassidakis
Affiliations
- Ioanna Xagoraris
- 1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- Konstantina Stathopoulou
- 1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- Stefanie Renken
- 1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- Andreas Lundqvist
- 1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- Francois Xavier Claret
- 2 The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Elias Drakos
- 3 Department of Pathology, University of Crete, Medical School, Heraklion Crete, Greece
- Georgios Z. Rassidakis
- 1 Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- DOI
-
https://doi.org/10.1097/01.HS9.0000890776.31358.d3
- Journal volume & issue
-
Vol. 6
pp.
23
– 24
WeChat QR code